Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone‐refractory prostate carcinoma

BACKGROUND The objective of the current study was to evaluate the efficacy and toxicity of weekly paclitaxel, oral etoposide, and estramustine phosphate in the treatment of patients with advanced, hormone‐refractory prostate carcinoma. METHODS Patients with hormone‐refractory prostate carcinoma who...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancer 2003-11, Vol.98 (10), p.2192-2198
Hauptverfasser:	Meluch, Anthony A., Greco, F. Anthony, Morrissey, Lisa H., Raefsky, Eric L., Steis, Ronald G., Butts, James A., Hainsworth, John D.
Format:	Artikel
Sprache:	eng
Schlagworte:	etoposide hormone‐refractory prostate carcinoma weekly paclitaxel
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!